An Interview with Innocan Pharma’s CEO, Iris Bincovich. Innocan Pharma is gaining attention for its innovative pain relief solutions — particularly through its slow-release injection technology. This cutting-edge approach delivers synthetic Cannabidi...
Almonty Industries Inc.(TSX:AII) , a company who specializes in acquiring and optimizing distressed and underperforming tungsten operations and assets. Lyndsay Malchuk, with the Market Online, recently had the pleasure to sit down with President and CEO Lewis Black. ...
Lyndsay Malchuk
|
December 27, 2024
|
As you will see in the full video above, Brianne Gardner , senior wealth manager at Velocity Investments, Raymond James Canada reviews her past picks from September to see if they are on the money and she gives three new diversified picks for 2025 in healthcare, ener...
Coreena Robertson
|
December 19, 2024
|
TSX this week The TSX has experienced a rocky week, marked by five consecutive sessions of declines. This downturn coincided with the unexpected resignation of Canada’s Finance Minister , Chrystia Freeland, just hours before she was scheduled to pre...
Jonathon Brown
|
December 19, 2024
|
As 2024 draws to a close, it is worth considering new investments for the future. A successful investment in the technology sector requires a sound strategy, thorough research, and an understanding of the ins and outs of the industry. We have summarized key points for in...
Mario Hose
|
December 16, 2024
|
Stephen Whiteside of TheUpTrend.com evaluates near-term upside in Costco, Broadcom, Adobe Systems, Steel Dynamics, Warner Bros, Arm Holdings, Imperial Oil, First Quantum Minerals, Microstrategy and more in Friday’s Morning Market Outlook. Navigate th...
TheUpTrend
|
December 13, 2024
|
Stephen Whiteside of TheUpTrend.com guides you through recent trading in BlackBerry, Constellation Software, Lightspeed Commerce, Advanced Micro Devices, Salesforce, NVIDIA, the ARK family of ETFs and more in Wednesday’s Morning Market Outlook. Navig...
TheUpTrend
|
December 11, 2024
|
By Brad Sorensen, CFA, Zacks Research. NurExone Biologic (TSXV:NRX; OTCQB:NRXBF) is developing a product known as ExoPTEN that is designed to treat patients with acute spinal cord injuries, while also conducting preclinical tests for other conditions that ExoPTEN m...
Research
|
December 11, 2024
|
Click here for the full report . This is sponsored content issued on behalf of Nextech3D.AI Corp., please see full disclaimer here .
Research
|
December 10, 2024
|
The immersive technology market size continues generating traction with the market projected to reach US$159.94 billion in 2024, according to market research . In the coming years, it will continue increasing at a rapid rate to reach US$638.69 billion in 2028, represent...
Jocelyn Aspa
|
December 3, 2024
|